West Lafayette, IN1 Active Studies

Parkinsons Disease Clinical Trials in West Lafayette, IN

Find 1 actively recruiting parkinsons disease clinical trials in West Lafayette, IN. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
120
Enrolling

Recruiting Parkinsons Disease Studies in West Lafayette

About Parkinsons Disease Clinical Trials in West Lafayette

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in West Lafayette, IN. These studies are seeking a combined 120 participants. Research is being sponsored by Teachers College, Columbia University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in West Lafayette — FAQ

Are there parkinsons disease clinical trials in West Lafayette?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in West Lafayette, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in West Lafayette?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the West Lafayette research site will contact you about next steps.

Are clinical trials in West Lafayette free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many West Lafayette studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in West Lafayette are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov